Bio-IT World July 25, 2024
By Bio-IT World Team

Form Bio and PacBio announced a range of new initiatives aimed at advancing and unifying the AAV industry; Insilico Medicine has introduced new products under Pharma AI: Biology42: PandaOmics Box, Precious-3 GPT, and Science42: DORA; and more.

Form Bio and PacBio announced a range of new initiatives aimed at advancing and unifying the adeno-associated virus (AAV) industry. The initiatives—including an AAV data dictionary, open-source tools, and more—are being driven by a new AAV Working Group, jointly assembled by Form Bio and PacBio and composed of leading AAV experts across industry and academia. Though AAV is recognized as one of the most promising gene therapy technologies due to its non-pathogenic nature, AAV-based program collaborations are often hindered...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations

Share This Article